Pitavastatin inhibited growth and colony formation and induced arrest at the G1 phase of liver cancer Huh-7 and SMMC7721 cells. It also promoted caspase-9 and caspase-3 cleavage. Pitavastatin reduced tumor growth and improved the survival of tumor-bearing mice. This evidence concerns the gene CASP3 and neoplasm.